Trading · Founded 1995 · www.hic.in · BSE 531663 · · ISIN INE139D01020
No Notes Added Yet
Business
Yuvraaj Hygiene Product Ltd. is an Indian company operating in the Trading sector, specifically within the Trading industry. Given its name, the company's core business model is likely centered on the procurement, distribution, and sale of various hygiene-related products. It acts as an intermediary, sourcing products from manufacturers or other suppliers and selling them to a diverse customer base, which may include retailers, wholesalers, institutional buyers, or potentially even direct consumers. The company makes money by earning a margin on the difference between the purchase price and the selling price of the hygiene products it trades.
Revenue Mix
Without specific financial data, the exact revenue mix or breakdown of key segments is unavailable. However, it can be inferred that the company's segments would primarily revolve around different categories of hygiene products, such as personal hygiene (e.g., soaps, sanitizers, dental care), home hygiene (e.g., cleaning products, disinfectants), or institutional hygiene supplies.
Industry
The trading industry for hygiene products in India is characterized by its high fragmentation and competitive intensity. It involves numerous players ranging from small regional distributors to larger national entities. Success in this industry often depends on efficient supply chain management, strong distribution networks, competitive pricing, and robust relationships with both suppliers and customers. Yuvraaj Hygiene Product Ltd. likely operates within this competitive landscape, positioning itself through its product portfolio, geographical reach, or specific customer relationships. Without further information, its precise standing against peers is not discernible.
MOAT
For a pure trading company, durable competitive advantages (moats) are generally more challenging to establish compared to manufacturing companies. Potential, though often limited, moats could include:
Efficient Distribution Network: A well-established and efficient logistics and distribution system that allows for timely and cost-effective delivery across a wide area.
Supplier Relationships: Exclusive distribution rights or strong, long-standing relationships with key hygiene product manufacturers, providing access to desirable products or better terms.
Customer Relationships: Deep-seated relationships and trust with a broad base of retailers or institutional clients, leading to consistent orders.
Scale: Achieving significant volume, which can lead to better procurement prices and greater operational efficiencies.
However, without specific details, the company's competitive advantage is likely to be based on operational efficiency and relationship management rather than strong, structural moats.
Growth Drivers
Key factors that could drive growth for Yuvraaj Hygiene Product Ltd. over the next 3-5 years include:
Increasing Hygiene Awareness: Growing public consciousness and demand for hygiene products in India, driven by health concerns and rising disposable incomes.
Market Expansion: Expanding its distribution network into new geographical regions or diversifying into new product categories within the hygiene segment.
New Distribution Agreements: Securing exclusive or preferred distribution rights for popular national or international hygiene brands.
Urbanization and Modern Trade Growth: Leveraging the expansion of organized retail and e-commerce channels in India to reach a wider customer base.
Operational Efficiency: Improving supply chain and logistics to enhance margins and competitiveness.
Risks
Intense Competition: The fragmented nature of the trading industry can lead to price wars and pressure on profit margins.
Supply Chain Disruptions: Reliance on external manufacturers and logistics partners makes the company vulnerable to disruptions in supply or transportation.
Inventory Management: Risks associated with inventory obsolescence, damage, or holding costs, especially for products with shelf lives.
Customer & Supplier Concentration: Over-reliance on a few key suppliers or large customers could pose a risk if those relationships sour or terms change.
Regulatory Changes: Evolving quality standards, import/export regulations, or taxation policies related to hygiene products could impact operations.
Working Capital Management: Managing cash flow effectively given the typical credit cycles in trading businesses.
Management & Ownership
Specific information regarding the promoters, management team's experience, or detailed ownership structure of Yuvraaj Hygiene Product Ltd. is not publicly available in this context. Generally, for Indian "Ltd." companies, there is a promoter group holding a significant stake, with potentially some public shareholding.
Outlook
Yuvraaj Hygiene Product Ltd. operates in a sector poised for growth in India, driven by increasing health consciousness and disposable incomes. The bull case envisions the company successfully expanding its distribution reach, securing favorable supplier partnerships, and effectively capitalizing on the rising demand for hygiene products through efficient operations. This could lead to steady revenue growth and stable, albeit potentially thin, profit margins. The bear case involves the company struggling with intense competition, leading to margin erosion and difficulty in scaling operations. Challenges in managing a complex supply chain, unexpected shifts in consumer preferences, or failure to adapt to evolving market dynamics (e.g., e-commerce growth) could also hinder performance. Overall, the company's future hinges on its ability to maintain operational efficiencies, foster strong relationships across its value chain, and navigate the competitive and fragmented trading landscape effectively.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 5 | 8 | 11 | 19 | 9 | 8 | 10 | 9 | 12 | 16 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 5 | 8 | 11 | 19 | 9 | 8 | 10 | 9 | 12 | 16 |
| Total Expenditure | 5 | 7 | 9 | 16 | 7 | 6 | 8 | 8 | 10 | 14 |
| Operating Profit | 0 | 1 | 2 | 3 | 2 | 1 | 2 | 1 | 2 | 3 |
| Interest | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | 0 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 2 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0 | 0 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 2 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -0 | 0 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 2 |
| Adjusted Earnings Per Share | -0 | 0.1 | 0.2 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 13 | 11 | 13 | 12 | 13 | 12 | 15 | 18 | 19 | 19 | 46 | 47 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Total Income | 13 | 11 | 13 | 12 | 13 | 13 | 16 | 19 | 20 | 19 | 46 | 47 |
| Total Expenditure | 11 | 10 | 14 | 13 | 13 | 13 | 16 | 19 | 20 | 18 | 39 | 40 |
| Operating Profit | 1 | 0 | -1 | -1 | -0 | 0 | 1 | -0 | -0 | 1 | 7 | 8 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | -1 | -3 | -3 | -2 | -2 | -0 | -2 | -1 | 0 | 6 | 5 |
| Provision for Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 |
| Profit After Tax | -1 | -1 | -3 | -2 | -2 | -2 | -0 | -1 | -1 | -0 | 6 | 5 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -1 | -1 | -3 | -2 | -2 | -2 | -0 | -1 | -1 | -0 | 6 | 5 |
| Adjusted Earnings Per Share | -0.1 | -0.1 | -0.4 | -0.4 | -0.3 | -0.3 | -0 | -0.2 | -0.1 | -0 | 0.6 | 0.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 142% | 37% | 31% | 13% |
| Operating Profit CAGR | 600% | 0% | 0% | 21% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -41% | 89% | 51% | 27% |
| ROE Average | 0% | 0% | 0% | -28% |
| ROCE Average | 115% | 35% | 17% | 0% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 5 | 4 | 3 | 1 | -1 | -3 | -3 | -3 | -4 | -5 | 1 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 2 | 3 | 3 | 3 | 5 | 5 | 9 | 7 | 7 | 7 | 6 |
| Other Non-Current Liabilities | 0 | -0 | 1 | 0 | 0 | 0 | -0 | -0 | -0 | 0 | 1 |
| Total Current Liabilities | 6 | 5 | 6 | 7 | 6 | 6 | 3 | 4 | 4 | 5 | 6 |
| Total Liabilities | 13 | 12 | 12 | 11 | 10 | 8 | 9 | 8 | 7 | 8 | 14 |
| Fixed Assets | 5 | 5 | 5 | 4 | 3 | 2 | 2 | 2 | 1 | 2 | 5 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 6 | 9 |
| Total Assets | 13 | 12 | 12 | 11 | 10 | 8 | 9 | 8 | 7 | 8 | 14 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -1 | -0 | 0 | -0 | -2 | 0 | 0 | 0 | 0 | 0 | 6 |
| Cash Flow from Investing Activities | 1 | 0 | -0 | -0 | -0 | -0 | -1 | -0 | 0 | -0 | -4 |
| Cash Flow from Financing Activities | 0 | 0 | -0 | 0 | 2 | 0 | 0 | -0 | -0 | 0 | -1 |
| Net Cash Inflow / Outflow | -0 | -0 | -0 | -0 | 0 | -0 | 0 | -0 | 0 | -0 | 0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.08 | -0.11 | -0.4 | -0.36 | -0.28 | -0.26 | -0.04 | -0.16 | -0.13 | -0.04 | 0.65 |
| CEPS(Rs) | 0.09 | -0 | -0.18 | -0.17 | -0.12 | -0.1 | 0.08 | -0.1 | -0.09 | 0.01 | 0.75 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 0.73 | 0.61 | 0.35 | 0.03 | -0.2 | -0.46 | -0.5 | -0.39 | -0.51 | -0.55 | 0.11 |
| Core EBITDA Margin(%) | 10.64 | 3.95 | -5.19 | -5.91 | -2.59 | -3.53 | -2.82 | -5.45 | -4.11 | 2.67 | 14.53 |
| EBIT Margin(%) | 1.66 | -3.26 | -15.85 | -16.51 | -10.21 | -8.56 | -2.14 | -3.46 | -2.11 | 0.44 | 12.55 |
| Pre Tax Margin(%) | -5.35 | -10.87 | -21.98 | -22.95 | -17.91 | -17.5 | -2.58 | -8.01 | -6.33 | 0.32 | 12.37 |
| PAT Margin (%) | -4.31 | -7.25 | -20.53 | -20.95 | -16.5 | -15.99 | -2.02 | -7.44 | -5.84 | -1.68 | 12.37 |
| Cash Profit Margin (%) | 4.68 | -0.04 | -9.38 | -9.77 | -6.73 | -6.38 | 3.68 | -4.82 | -3.85 | 0.56 | 14.38 |
| ROA(%) | -4.1 | -6.16 | -21.8 | -21.98 | -20.29 | -21.28 | -3.77 | -16.86 | -15.99 | -4.7 | 54.33 |
| ROE(%) | -10.8 | -17.05 | -82.75 | -199.43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ROCE(%) | 1.89 | -3.12 | -20.77 | -25.14 | -18.76 | -16.39 | -6.06 | -13.49 | -12.65 | 3.47 | 115.13 |
| Receivable days | 60.99 | 49.95 | 36.18 | 36.55 | 29.22 | 24.18 | 24.14 | 28.72 | 30.8 | 30.51 | 16 |
| Inventory Days | 118.8 | 185.48 | 152.36 | 153.42 | 146.3 | 152.08 | 110.31 | 84.67 | 64.54 | 61.86 | 32.03 |
| Payable days | 79.07 | 72.24 | 88.26 | 122.52 | 103.45 | 83.69 | 81.13 | 83.92 | 104.59 | 133.56 | 61.02 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.5 |
| Price/Book(x) | 10.78 | 2.27 | 2.17 | 0 | -3.68 | -1.06 | -1.99 | -3.42 | -2.95 | -2.94 | 110.12 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 4.54 | 1.49 | 0.88 | 1.11 | 1.08 | 1.02 | 1.09 | 1.05 | 1.07 | 1.16 | 2.48 |
| EV/Core EBITDA(x) | 42.6 | 37.74 | -18.66 | -20.87 | -243.8 | 97.08 | 28.96 | -118.96 | -839.63 | 40.22 | 16.62 |
| Net Sales Growth(%) | -21.59 | -18.3 | 22.5 | -7.49 | 6.75 | -4.43 | 24.74 | 21.14 | 5.57 | -2.13 | 143.85 |
| EBIT Growth(%) | -81.74 | -259.98 | -495.75 | 3.68 | 33.96 | 19.91 | 66.95 | -93.28 | 35.71 | 121.14 | 6494.91 |
| PAT Growth(%) | -345.13 | -37.47 | -246.75 | 5.57 | 15.95 | 7.39 | 83.32 | -340.65 | 17.38 | 71.07 | 1818.78 |
| EPS Growth(%) | -345.12 | -37.42 | -246.85 | 10.3 | 20.39 | 7.41 | 83.31 | -260.41 | 17.4 | 71.1 | 1821.01 |
| Debt/Equity(x) | 1.18 | 1.49 | 2.47 | 14.05 | -6.71 | -2.77 | -2.65 | -2.27 | -1.59 | -1.54 | 5.28 |
| Current Ratio(x) | 1.19 | 1.39 | 1.03 | 0.87 | 1.01 | 0.95 | 2 | 1.48 | 1.17 | 1.17 | 1.61 |
| Quick Ratio(x) | 0.27 | 0.3 | 0.19 | 0.19 | 0.17 | 0.17 | 0.48 | 0.49 | 0.44 | 0.41 | 0.77 |
| Interest Cover(x) | 0.24 | -0.43 | -2.59 | -2.56 | -1.33 | -0.96 | -4.92 | -0.76 | -0.5 | 3.49 | 66.91 |
| Total Debt/Mcap(x) | 0.12 | 0.7 | 1.26 | 0 | 1.52 | 2.41 | 1.24 | 0.62 | 0.51 | 0.5 | 0.06 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.93 | 74.93 | 74.93 | 74.93 | 63.9 | 63.9 | 52.86 | 52.86 | 52.86 | 52.86 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 25.07 | 25.07 | 25.07 | 25.07 | 36.1 | 36.1 | 47.14 | 47.14 | 47.14 | 47.14 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 6.79 | 6.79 | 6.79 | 6.79 | 5.79 | 5.79 | 4.79 | 4.79 | 4.79 | 4.79 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 2.27 | 2.27 | 2.27 | 2.27 | 3.27 | 3.27 | 4.27 | 4.27 | 4.27 | 4.27 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +142% | +37% | +31% | +13% |
| Operating Profit CAGR | +600% | — | — | +21% |
| PAT CAGR | — | — | — | — |
| Share Price CAGR | -41% | +89% | +51% | +27% |
| ROE Average | 0% | 0% | 0% | -28% |
| ROCE Average | +115% | +35% | +17% | 0% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.93 | 74.93 | 74.93 | 74.93 | 63.9 | 63.9 | 52.86 | 52.86 | 52.86 | 52.86 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 25.07 | 25.07 | 25.07 | 25.07 | 36.1 | 36.1 | 47.14 | 47.14 | 47.14 | 47.14 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 6.79 | 6.79 | 6.79 | 6.79 | 5.79 | 5.79 | 4.79 | 4.79 | 4.79 | 4.79 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 2.27 | 2.27 | 2.27 | 2.27 | 3.27 | 3.27 | 4.27 | 4.27 | 4.27 | 4.27 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.